Arena Investors’s Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CRU.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-434,000
Closed -$43K 187
2022
Q2
$43K Buy
+434,000
New +$80.7K 0.02% 108

Other funds holding CRU.WS

Arena Investors's CRU.WS Position: Q3 2022 in Review

Arena Investors sold out of Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CRU.WS) in Q3 2022, closing a stake of 434,000 shares — an estimated $43K sold.

Arena Investors first reported a position in CRU.WS in Q2 2022 and held it in 1 quarter. The position peaked at $43K in Q2 2022. 8 funds tracked by Wall St. Rank hold CRU.WS as of Q3 2022.

  • Arena Investors reported no remaining Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Arena Investors sold 434,000 Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2022, an estimated $43K.
  • Arena Investors first reported a position in Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q2 2022 and held it in 1 quarter.
  • Arena Investors's Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $43K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2022.

Based on Arena Investors's 13F filing for Q3 2022, filed 2 Nov 2022.